Michael Kaseta
CIK 1724346 · CFO and COO · last filed 2026-07-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$32.92M
Companies
4
Total Filings
55
Lifetime Open-Market Net
-$18.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LQDA | CFO and COO | 364,782 | $90.21 | $32.91M | -$18.20M | 41 | 2026-07-14 |
| HRTX | Director | 53,960 | $0.32 | $17.2K | $0 | 4 | 2026-02-03 |
| ALIMERA SCIENCES INC (ALIM) Delisted | Director | — | $5.54 | — | $0 | 2 | 2023-10-04 |
| Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Chief Financial Officer | 15,000 | — | — | $0 | 2 | 2018-03-19 |
Recent Filings · Page 5 of 6
55 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-04-10 | LQDA | Grant (A) | +1,927 | $9.5K | EDGAR |
| 2023-03-28 | ALIMERA SCIENCES INC (ALIM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-02 | LQDA | Exer (M) | +9,375 | $0 | EDGAR |
| 2023-01-13 | LQDA | Grant (A) | +124,667 | $0 | EDGAR |
| 2022-09-14 | LQDA | Buy (P) | +8,000 | $47.9K | EDGAR |
| 2022-09-01 | LQDA | Buy (P) | +1,927 | $9.5K | EDGAR |
| 2022-08-01 | LQDA | Grant (A) | — | $0 | EDGAR |
| 2022-06-01 | LQDA | Buy (P) | +18,700 | $74.9K | EDGAR |
| 2022-01-19 | LQDA | Grant (A) | — | $0 | EDGAR |
| 2021-11-12 | LQDA | Mixed | +9,250 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.